Active Stocks

Fri Dec 05 2025 15:59:59

Eternal share price
292.40 -1.15%

Infosys share price
1,615.95 1.14%

Tata Steel share price
167.10 0.21%

Tata Motors Passenger Vhcls share price
353.50 -0.83%

ITC share price
404.80 0.43%

Business News > Mint Authors > Naomi Kresge

Naomi Kresge

ARTICLES BY NAOMI KRESGE

AstraZeneca vaccine (Photo: Reuters)

Astra-Oxford covid vaccine: Does it match with rivals? Here’s what we know

3 min read . 23 Nov 2020

President Donald Trump (Photo: AP)

Why Trump’s covid-19 antibody cocktail won’t be widely available

2 min read . 15 Oct 2020

Novartis CEO Vasant Narasimhan said researchers will also need time to see whether vaccines work differently for the young and the elderly (Photo: Mint)

It’ll take more than vaccines to fight covid: Novartis CEO Vas Narasimhan

1 min read . 30 Sept 2020

The headquarters of biopharmaceutical company BioNTech are seen in Mainz, Germany (Photo: Reuters)

Confident of its covid vaccine, German company buys factory to double production

1 min read . 17 Sept 2020

Though four out of five people will probably have mild symptoms, the new coronavirus can be deadly for the elderly and people with conditions such as diabetes and high blood pressure

Coronavirus tally may be tip of iceberg as sick go untested

5 min read . 10 Jun 2020

AstraZeneca’s Lynparza drug was originally approved to treat ovarian tumours. Photo: Bloomberg

AstraZeneca’s Lynparza drug slows spread of inherited breast cancer

3 min read . 04 Jun 2017

Though Deutsche Bank told staff last month that it was scaling back bonuses, the full magnitude of the cuts hadn’t been reported. Photo: Bloomberg

Deutsche Bank cuts bonus pool almost 80% on legal costs

2 min read . 27 Feb 2017

Roche’s drugs have already revolutionized the treatment of breast cancer. Photo: Bloomberg

Roche fights Roche in bid to preserve $9 billion drug business

3 min read . 13 Feb 2017

Bayer will need to integrate a firm known for making the herbicide Agent Orange for use in the Vietnam War and tangling with environmental groups over genetically-modified crops. Photo: Reuters

Bayer mulls dropping Monsanto name as cure for brand headache

3 min read . 20 Sept 2016

Bayer’s dermatology products include the eczema treatment Desonate and Finacea for rosacea. Photo: AFP

Bayer said to explore sale of $1.1 billion dermatology business

1 min read . 09 Sept 2016

Renault recalls 15,800 Captur SUVs, offers emission software upgrade for 7 lakh vehicles

1 min read . 20 Jan 2016

Volkswagen to speed up other cost cuts in the wake of a diesel emissions-cheating scandal. Photo: Abhijit Bhatlekar/Mint

Volkswagen to cut spending by $1.1 billion amid diesel scandal

1 min read . 13 Oct 2015

Luxury auto makers such as Mercedes-Benz say they are committed to keeping data safe and secure. Still, consumer watchdogs are on alert, especially in Europe, which is sensitive to privacy concerns. Photo: Bloomberg

Auto makers’ push to tap data goldmine faces privacy threat

3 min read . 02 Sept 2015

Fiat Chrysler announced plans last year to sell 10% of Ferrari in an IPO and distribute its remaining 80% stake in the supercar maker to its own investors. Photo: Bloomberg

Ferrari files for share listing on New York Stock Exchange

2 min read . 24 Jul 2015

Bayer didn’t specify whether it would sell the plastics unit in an initial public offering (IPO) or distribute shares in it to stockholders. Photo: Bloomberg

Bayer plans stock-market listing for plastics unit

2 min read . 18 Sept 2014

US’ Matt Besler during a training session at the Arena da Amazonia on 22 June. Photo: Paulo Duarte/AP

Peanut butter and Parmesan

3 min read . 25 Jun 2014

Bayer’s $14.2 billion Merck buy shows industry divide on OTC

4 min read . 08 May 2014

The deal is the second large consumer transaction in a month of reshuffling in the pharmaceutical industry as the biggest drugmakers drop units that aren’t leaders in a particular segment. Photo: Bloomberg

Bayer to buy Merck’s consumer unit for $14.2 billion

2 min read . 06 May 2014

Activists are pushing for bigger discount on Biocon breast cancer drug, saying they’re hoping for the kind of ripple effect that resulted when competition among Indian generic-drug makers drove down prices for HIV medicines. Photo: Aniruddha Chowdhury/Mint

Biocon’s copy of Roche breast cancer drug still expensive for India

4 min read . 21 Jan 2014

Bayer is offering Algeta shareholders a smaller premium than other biotechnology companies have gotten over the past five years. Photo: Bloomberg

Bayer in talks to buy cancer partner Algeta for $2.4 billion

3 min read . 27 Nov 2013